New report on Systemic Fungal Infection Therapeutics Market IndiaNews-Medical.netThis Frost & Sullivan research service titled Systemic Fungal Infection Therapeutics Market India provides an analysis of the current diagnostic and ...Research and Markets: Advances in Diagnostic Tests Facilitate More Targeted ...Earthtimes (press release)all 11 news articles »
news articles
The Budding Market of Superfruits - Natural Products Industry Insider
The Budding Market of SuperfruitsNatural Products Industry Insider... phytochemical diversity and density, basic research intensity, clinical research progress, and popularity based on sensory appeal and market demand. ...Mango: The leading superfruitArab Newsall 2 news articles »
China, India on rise as research partners - The Australian
China, India on rise as research partnersThe AustralianRESEARCH collaboration between Australia and China has nearly doubled in the past decade and India is on the rise as a research partner. ...Australia Substantially Increases Research Collaboration with China, According ...PR Newswire (press release)all 19 news articles »
Kendle Receives Approval From Indian Government To Proceed With - Pharmaceutical Online (press release)
Kendle Receives Approval From Indian Government To Proceed WithPharmaceutical Online (press release)Kendle's expansion in the quickly maturing India market reflects the growing importance of the country to the global clinical research market. ...Kendle establishing operations centre in Indian economic zonePharma TimesKendle to Share Insights at Upcoming DIA EuroMeeting and Cambridge Healthtech ...PR Newswire (press release)all 14 news articles »
Kendle plans operations center in India - Cincinnati.com
Kendle plans operations center in IndiaCincinnati.com... the downtown-based clinical research organization, Thursday announced the company has received approval to develop of a new operations center in India. ...Kendle to open operations center in IndiaCincinnati Business CourierGujarat's first IT SEZ clicks as Kendle logs on to MindspaceBusiness Standardall 5 news articles »
Money Money Money: Diabetes Research Funding - Diabetes Health (press release)
Money Money Money: Diabetes Research FundingDiabetes Health (press release)From the idea stage, to preclinical (basic) investigations, to clinical trials and beyond, the scientific research required to understand a disease and ...Collins, Dorgan Introduce Bill To Reauthorize Critical Diabetes Research FundingR & D Magazineall 2 news articles »
Kendle Receives Approval From Indian Government to Proceed With Development of ... - PR Newswire (press release)
Kendle Receives Approval From Indian Government to Proceed With Development of ...PR Newswire (press release)Kendle's expansion in the quickly maturing India market reflects the growing importance of the country to the global clinical research market. ...Market Report -- In Play (KNDL)MSN Moneyall 15 news articles »
Reportlinker Adds Cell and Stem Cell Therapies for Diabetes - PR Newswire (press release)
PRLog.Org (press release)Reportlinker Adds Cell and Stem Cell Therapies for DiabetesPR Newswire (press release)Despite large research work done in the area of islet cell applications for the treatment of diabetes, and large number of completed and active clinical ...Demand for Stem Cells Growing Fast, Many Turning to the Allure of Medical TourismSingularity Hub (blog)all 39 news articles »
Research and Markets: Cell and Stem Cell Therapies for Diabetes - Addressing ... - Earthtimes (press release)
PRLog.Org (press release)Research and Markets: Cell and Stem Cell Therapies for Diabetes - Addressing ...Earthtimes (press release)Despite large research work done in the area of islet cell applications for the treatment of diabetes, and large number of completed and active clinical ...Demand for Stem Cells Growing Fast, Many Turning to the Allure of Medical TourismSingularity Hub (blog)all 30 news articles »
Health gets a strong dose of funds - Times of India
Health gets a strong dose of fundsTimes of IndiaBiotech bets: The hike in weighted deduction on in-house R&D expenditure from 150% to 200%, the inclusion of expenses on clinical trials and product patent ...Life sciences sector calls duty rationalisation and infrastructure status in ...pharmabiz.comall 38 news articles »

